13
Participants
Start Date
October 3, 2013
Primary Completion Date
April 14, 2015
Study Completion Date
April 14, 2015
Clonidine (Duraclon®)
"Clonidine at dosing intervals of 6, 8, 12, 18 or 24 hours. If the following is observed the event will be recorded, and no additional clonidine will be given and blood will be drawn to measure plasma level of clondine.~* 10 mm Hg reduction in MAP or MAP ≤ 40 mm Hg sustained for ≥30 min after administration~* 20% drop in HR from the infant's baseline, sustained for ≥30 min after administration~* HR ≤70/min, sustained for ≥30 min after administration"
Johns Hopkins Hospital, Baltimore
University of Maryland
OTHER
Johns Hopkins University
OTHER